7.47
price down icon1.45%   -0.11
after-market Handel nachbörslich: 7.47
loading
Schlusskurs vom Vortag:
$7.58
Offen:
$7.555
24-Stunden-Volumen:
6.38M
Relative Volume:
0.98
Marktkapitalisierung:
$1.21B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$422.82M
KGV:
3.2763
EPS:
2.28
Netto-Cashflow:
$-637.33M
1W Leistung:
-4.72%
1M Leistung:
+6.56%
6M Leistung:
+5.81%
1J Leistung:
-34.47%
1-Tages-Spanne:
Value
$7.435
$7.79
1-Wochen-Bereich:
Value
$7.36
$7.88
52-Wochen-Spanne:
Value
$5.01
$15.22

Novavax Inc Stock (NVAX) Company Profile

Name
Firmenname
Novavax Inc
Name
Telefon
240-268-2000
Name
Adresse
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Name
Mitarbeiter
1,992
Name
Twitter
@novavax
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
NVAX's Discussions on Twitter

Vergleichen Sie NVAX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NVAX
Novavax Inc
7.47 1.23B 1.08B 422.82M -637.33M 2.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.02 100.52B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.70 61.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
446.51 59.29B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
712.20 43.09B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
306.05 35.42B 3.81B -644.79M -669.77M -6.24

Novavax Inc Stock (NVAX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-20 Herabstufung BofA Securities Neutral → Underperform
2025-06-17 Eingeleitet Citigroup Sell
2025-02-28 Eingeleitet BTIG Research Buy
2024-07-30 Herabstufung JP Morgan Neutral → Underweight
2024-05-10 Hochstufung BofA Securities Underperform → Neutral
2024-05-10 Hochstufung JP Morgan Underweight → Neutral
2023-08-09 Hochstufung B. Riley Securities Neutral → Buy
2023-04-20 Herabstufung TD Cowen Outperform → Market Perform
2023-03-01 Herabstufung B. Riley Securities Buy → Neutral
2023-01-09 Bestätigt B. Riley Securities Buy
2022-12-30 Bestätigt H.C. Wainwright Buy
2022-12-02 Eingeleitet Jefferies Hold
2022-09-22 Herabstufung JP Morgan Neutral → Underweight
2022-05-20 Eingeleitet BofA Securities Underperform
2022-02-23 Bestätigt B. Riley Securities Buy
2022-02-22 Fortgesetzt Jefferies Buy
2022-01-21 Eingeleitet Cowen Outperform
2021-05-12 Herabstufung JP Morgan Overweight → Neutral
2020-12-14 Eingeleitet Jefferies Buy
2020-08-06 Bestätigt H.C. Wainwright Buy
2020-08-05 Hochstufung JP Morgan Neutral → Overweight
2020-08-05 Herabstufung Ladenburg Thalmann Neutral → Sell
2020-07-16 Bestätigt H.C. Wainwright Buy
2020-07-08 Herabstufung Ladenburg Thalmann Buy → Neutral
2020-06-29 Bestätigt B. Riley FBR Buy
2020-06-29 Bestätigt H.C. Wainwright Buy
2020-06-05 Hochstufung JP Morgan Underweight → Neutral
2020-05-28 Bestätigt B. Riley FBR Buy
2020-05-12 Bestätigt H.C. Wainwright Buy
2020-04-30 Bestätigt H.C. Wainwright Buy
2019-11-27 Fortgesetzt B. Riley FBR Buy
2019-08-14 Bestätigt H.C. Wainwright Buy
2019-02-28 Herabstufung Piper Jaffray Overweight → Underweight
2018-12-18 Eingeleitet Ladenburg Thalmann Buy
2018-12-11 Eingeleitet Oppenheimer Outperform
2018-11-26 Hochstufung Piper Jaffray Neutral → Overweight
2018-09-21 Hochstufung JP Morgan Underweight → Overweight
2018-03-29 Hochstufung Seaport Global Securities Neutral → Buy
Alle ansehen

Novavax Inc Aktie (NVAX) Neueste Nachrichten

pulisher
04:23 AM

Novavax Inc. recovery potential after sell offWeekly Gains Summary & Smart Investment Allocation Tips - Newser

04:23 AM
pulisher
02:45 AM

How high can Novavax Inc. stock goInsider Buying & Daily Entry Point Trade Alerts - Newser

02:45 AM
pulisher
12:52 PM

Is Novavax Inc. trending in predictive chart modelsWatch List & Free Expert Verified Stock Movement Alerts - Newser

12:52 PM
pulisher
07:06 AM

Candlestick signals on Novavax Inc. stock today2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - Newser

07:06 AM
pulisher
06:19 AM

Can machine learning forecast Novavax Inc. recovery2025 Price Momentum & Reliable Entry Point Trade Alerts - Newser

06:19 AM
pulisher
04:09 AM

Price momentum metrics for Novavax Inc. explainedIndex Update & Free Technical Confirmation Trade Alerts - Newser

04:09 AM
pulisher
Aug 29, 2025

Novavax Initiates Coverage with Buy Rating and $10 Price Target - AInvest

Aug 29, 2025
pulisher
Aug 29, 2025

What earnings revisions data tells us about Novavax Inc.July 2025 Highlights & Reliable Breakout Forecasts - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Will Novavax Inc. stock go up soonEarnings Growth Report & Real-Time Volume Analysis - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Using RSI to spot recovery in Novavax Inc.July 2025 Final Week & Reliable Momentum Entry Alerts - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Why Novavax Inc. stock attracts strong analyst attentionJuly 2025 Volume & Consistent Profit Trading Strategies - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

How moving averages guide Novavax Inc. tradingAnalyst Upgrade & Stepwise Trade Execution Plans - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Is Novavax Inc. Forming a Bottom Pattern2025 Bull vs Bear & Target Return Focused Picks - beatles.ru

Aug 29, 2025
pulisher
Aug 29, 2025

How to monitor Novavax Inc. with trend dashboardsPrice Action & Daily Oversold Stock Bounce Ideas - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

What to expect from Novavax Inc. in the next 30 daysGDP Growth & Verified High Yield Trade Plans - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA - MSN

Aug 29, 2025
pulisher
Aug 29, 2025

Novavax Inc. stock daily chart insightsMarket Weekly Review & AI Powered Buy/Sell Recommendations - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Novavax Inc.’s volatility index tracking explainedProfit Target & AI Powered Market Entry Strategies - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Full technical analysis of Novavax Inc. stockRisk Management & Long Hold Capital Preservation Tips - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

What to do if you’re stuck in Novavax Inc.Recession Risk & Verified Momentum Watchlists - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Analyzing Novavax Inc. with multi timeframe chartsAnalyst Upgrade & Risk Adjusted Buy/Sell Alerts - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Can technical indicators confirm Novavax Inc.’s reversalDollar Strength & Long-Term Growth Portfolio Plans - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Using data filters to optimize entry into Novavax Inc.Layoff News & Growth Focused Stock Reports - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Momentum divergence signals in Novavax Inc. chartQuarterly Risk Review & Weekly Top Gainers Alerts - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

What technical models suggest about Novavax Inc.’s comebackEarnings Risk Report & Expert Approved Trade Ideas - Newser

Aug 29, 2025
pulisher
Aug 28, 2025

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S. - Eastern Progress

Aug 28, 2025

Finanzdaten der Novavax Inc-Aktie (NVAX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Novavax Inc-Aktie (NVAX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Alton Gregg H
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
28,805
King Rachel K.
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
25,190
Rodgers Richard J
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
24,690
MOTT DAVID M
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
60,890
DOUGLAS RICHARD
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
54,340
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Kapitalisierung:     |  Volumen (24h):